Lipid lowering therapy in particular patient populations

Dyslipidemia is a major risk factor for cardiovascular diseases. In daily practice, patients with different clinical settings such as acute coronary syndrome, familial hypercholesterolemia, diabetes mellitus, chronic renal failure are not uncommon. These patients require special evaluation regarding treatment strategy, choice of medications, drug-drug interactions and follow-up. Usually, these patients have not been adequately presented in large randomized controlled trials, thus it is hard to derive definite indications and treatment algorithms for this group of patients. European Society of Cardiology/the European Atherosclerosis Society 2019 guideline on dyslipidemia and lipid modification to reduce cardiovascular risk has provided detailed information on patients with different clinical setting and updated treatment recommendations.